Selected research
Industry Research
Liposome Encapsulation Services Industry Research Report 2026
Market perspective
The global Liposome Encapsulation Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Liposome Encapsulation Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Liposome Encapsulation Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Liposome Encapsulation Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Liposome Encapsulation Services include BOC Sciences, Evonik, Danaher, Merck, Creative Biolabs, Polymun Scientific, Lonza, CordenPharma and Baxter BioPharma Solutions, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Liposome Encapsulation Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Liposome Encapsulation Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Liposome Encapsulation Services Market by Company
BOC Sciences
Evonik
Danaher
Merck
Creative Biolabs
Polymun Scientific
Lonza
CordenPharma
Baxter BioPharma Solutions
Luye Pharma
GMPriority Pharma
Liposome Encapsulation Services Segment by Type
Hydrophilic Molecules
Hydrophobic Molecules
Macromolecules/Nucleic Acids
Others
Liposome Encapsulation Services Segment by Application
Pharmaceutical
Nutraceutical
Cosmetic
Liposome Encapsulation Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Encapsulation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liposome Encapsulation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Encapsulation Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Liposome Encapsulation Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hydrophilic Molecules
- Hydrophobic Molecules
- Macromolecules/Nucleic Acids
- Others
Applications
- Pharmaceutical
- Nutraceutical
- Cosmetic
Companies covered
- BOC Sciences
- Evonik
- Danaher
- Merck
- Creative Biolabs
- Polymun Scientific
- Lonza
- CordenPharma
- Baxter BioPharma Solutions
- Luye Pharma
- GMPriority Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Liposome Encapsulation Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Hydrophilic Molecules
- 2.2.3 Hydrophobic Molecules
- 2.2.4 Macromolecules/Nucleic Acids
- 2.2.5 Others
- 2.3 Liposome Encapsulation Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical
- 2.3.3 Nutraceutical
- 2.3.4 Cosmetic
- 2.4 Assumptions and Limitations
3 Liposome Encapsulation Services Breakdown Data by Type
- 3.1 Global Liposome Encapsulation Services Historic Market Size by Type (2021-2026)
- 3.2 Global Liposome Encapsulation Services Forecasted Market Size by Type (2027-2032)
4 Liposome Encapsulation Services Breakdown Data by Application
- 4.1 Global Liposome Encapsulation Services Historic Market Size by Application (2021-2026)
- 4.2 Global Liposome Encapsulation Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Liposome Encapsulation Services Market Perspective (2021-2032)
- 5.2 Global Liposome Encapsulation Services Growth Trends by Region
- 5.2.1 Global Liposome Encapsulation Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Liposome Encapsulation Services Historic Market Size by Region (2021-2026)
- 5.2.3 Liposome Encapsulation Services Forecasted Market Size by Region (2027-2032)
- 5.3 Liposome Encapsulation Services Market Dynamics
- 5.3.1 Liposome Encapsulation Services Industry Trends
- 5.3.2 Liposome Encapsulation Services Market Drivers
- 5.3.3 Liposome Encapsulation Services Market Challenges
- 5.3.4 Liposome Encapsulation Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Liposome Encapsulation Services Players by Revenue
- 6.1.1 Global Top Liposome Encapsulation Services Players by Revenue (2021-2026)
- 6.1.2 Global Liposome Encapsulation Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Liposome Encapsulation Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Liposome Encapsulation Services Head Office and Area Served
- 6.4 Global Liposome Encapsulation Services Players, Product Type & Application
- 6.5 Global Liposome Encapsulation Services Manufacturers Established Date
- 6.6 Global Liposome Encapsulation Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Liposome Encapsulation Services Market Size (2021-2032)
- 7.2 North America Liposome Encapsulation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Liposome Encapsulation Services Market Size by Country (2021-2026)
- 7.4 North America Liposome Encapsulation Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Liposome Encapsulation Services Market Size (2021-2032)
- 8.2 Europe Liposome Encapsulation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Liposome Encapsulation Services Market Size by Country (2021-2026)
- 8.4 Europe Liposome Encapsulation Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Liposome Encapsulation Services Market Size (2021-2032)
- 9.2 Asia-Pacific Liposome Encapsulation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Liposome Encapsulation Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Liposome Encapsulation Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Liposome Encapsulation Services Market Size (2021-2032)
- 10.2 South America Liposome Encapsulation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Liposome Encapsulation Services Market Size by Country (2021-2026)
- 10.4 South America Liposome Encapsulation Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Liposome Encapsulation Services Market Size (2021-2032)
- 11.2 Middle East & Africa Liposome Encapsulation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Liposome Encapsulation Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Liposome Encapsulation Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BOC Sciences
- 12.1.1 BOC Sciences Company Information
- 12.1.2 BOC Sciences Business Overview
- 12.1.3 BOC Sciences Revenue in Liposome Encapsulation Services Business (2021-2026)
- 12.1.4 BOC Sciences Liposome Encapsulation Services Product Portfolio
- 12.1.5 BOC Sciences Recent Developments
- 12.2 Evonik
- 12.2.1 Evonik Company Information
- 12.2.2 Evonik Business Overview
- 12.2.3 Evonik Revenue in Liposome Encapsulation Services Business (2021-2026)
- 12.2.4 Evonik Liposome Encapsulation Services Product Portfolio
- 12.2.5 Evonik Recent Developments
- 12.3 Danaher
- 12.3.1 Danaher Company Information
- 12.3.2 Danaher Business Overview
- 12.3.3 Danaher Revenue in Liposome Encapsulation Services Business (2021-2026)
- 12.3.4 Danaher Liposome Encapsulation Services Product Portfolio
- 12.3.5 Danaher Recent Developments
- 12.4 Merck
- 12.4.1 Merck Company Information
- 12.4.2 Merck Business Overview
- 12.4.3 Merck Revenue in Liposome Encapsulation Services Business (2021-2026)
- 12.4.4 Merck Liposome Encapsulation Services Product Portfolio
- 12.4.5 Merck Recent Developments
- 12.5 Creative Biolabs
- 12.5.1 Creative Biolabs Company Information
- 12.5.2 Creative Biolabs Business Overview
- 12.5.3 Creative Biolabs Revenue in Liposome Encapsulation Services Business (2021-2026)
- 12.5.4 Creative Biolabs Liposome Encapsulation Services Product Portfolio
- 12.5.5 Creative Biolabs Recent Developments
- 12.6 Polymun Scientific
- 12.6.1 Polymun Scientific Company Information
- 12.6.2 Polymun Scientific Business Overview
- 12.6.3 Polymun Scientific Revenue in Liposome Encapsulation Services Business (2021-2026)
- 12.6.4 Polymun Scientific Liposome Encapsulation Services Product Portfolio
- 12.6.5 Polymun Scientific Recent Developments
- 12.7 Lonza
- 12.7.1 Lonza Company Information
- 12.7.2 Lonza Business Overview
- 12.7.3 Lonza Revenue in Liposome Encapsulation Services Business (2021-2026)
- 12.7.4 Lonza Liposome Encapsulation Services Product Portfolio
- 12.7.5 Lonza Recent Developments
- 12.8 CordenPharma
- 12.8.1 CordenPharma Company Information
- 12.8.2 CordenPharma Business Overview
- 12.8.3 CordenPharma Revenue in Liposome Encapsulation Services Business (2021-2026)
- 12.8.4 CordenPharma Liposome Encapsulation Services Product Portfolio
- 12.8.5 CordenPharma Recent Developments
- 12.9 Baxter BioPharma Solutions
- 12.9.1 Baxter BioPharma Solutions Company Information
- 12.9.2 Baxter BioPharma Solutions Business Overview
- 12.9.3 Baxter BioPharma Solutions Revenue in Liposome Encapsulation Services Business (2021-2026)
- 12.9.4 Baxter BioPharma Solutions Liposome Encapsulation Services Product Portfolio
- 12.9.5 Baxter BioPharma Solutions Recent Developments
- 12.10 Luye Pharma
- 12.10.1 Luye Pharma Company Information
- 12.10.2 Luye Pharma Business Overview
- 12.10.3 Luye Pharma Revenue in Liposome Encapsulation Services Business (2021-2026)
- 12.10.4 Luye Pharma Liposome Encapsulation Services Product Portfolio
- 12.10.5 Luye Pharma Recent Developments
- 12.11 GMPriority Pharma
- 12.11.1 GMPriority Pharma Company Information
- 12.11.2 GMPriority Pharma Business Overview
- 12.11.3 GMPriority Pharma Revenue in Liposome Encapsulation Services Business (2021-2026)
- 12.11.4 GMPriority Pharma Liposome Encapsulation Services Product Portfolio
- 12.11.5 GMPriority Pharma Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst